PH Consulate visits LiVeritas Biosciences Lab in South San Francisco
SOUTH SAN FRANCISCO — The Philippine Consulate General in San Francisco, led by Consul General Neil Frank Ferrer, visited LiVeritas Biosciences Laboratory last August 6 to learn more about the company’s pioneering use of artificial intelligence (AI) in accelerating drug development, and to explore possible collaboration opportunities in the Philippines.
The Consulate takes pride in the fact that LiVeritas was co-founded by a Filipina, Dr. Lieza Danan, who serves as the company’s chief executive officer. Joining Dr. Danan were Co-Founder and Legal & Intellectual Property Strategy officer Eric Webostad, and Late-Stage Development CMC Manufacturing & Supply Chain officer Kenneth Co. Consul General Ferrer was accompanied by Consul and Economic officer Rowena Pangilinan-Daquipil, Trade Commissioner Anne Marie Kristine Umali and Economic Assistant Danica Vismonte.
Founded in 2021 by Dr. Danan, Webostad, and three Filipino professionals (a software engineer, a data analyst, and a data scientist), LiVeritas has developed proprietary AI-driven “digital scientist” tools that streamline the traditionally fragmented drug development process. These tools have already reduced clinical testing timelines from four weeks to just five days, with plans to shorten this further to under three days within the next quarter.
Specializing in Chemistry, Manufacturing, and Controls (CMC) analytics, LiVeritas integrates all data workflows into a single FDA-compliant operating system, removing inefficiencies and enabling faster submission of Investigational New Drug (IND) applications.
LiVeritas aims to expand its proprietary AI tools as well as increase its digital scientists within the next three years. While LiVeritas currently serves clients exclusively in the US, the company is open to exploring opportunities in the Philippines. The Consulate expressed readiness to support this endeavor.
